Skip to main content
ZEVRA THERAPEUTICS, INC. logo

ZEVRA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ZVRA ISIN · US4884452065 LEI · 254900CU6T74V18Y1W18 US Manufacturing
Filings indexed 830 across all filing types
Latest filing 2021-12-01 Director's Dealing
Country US United States of America
Listing US ZVRA

About ZEVRA THERAPEUTICS, INC.

https://zevra.com/

Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for patients with rare diseases. The company focuses on addressing significant unmet medical needs by combining a data-driven scientific approach with a patient-first perspective. Its portfolio includes commercial products such as MIPLYFFA®, an FDA-approved treatment for Niemann-Pick disease type C (NPC), and OLPRUVA®. Zevra Therapeutics also maintains a late-stage clinical pipeline, specializing in advancing promising medicines that face complex clinical and regulatory challenges for conditions with limited or no available treatments.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2021-12-01 English
FORM 4
Director's Dealing
2021-11-30 English
FORM 4
Director's Dealing
2021-11-23 English
FORM 4
Director's Dealing
2021-11-18 English
FORM 4
Director's Dealing
2021-11-11 English
FORM 424B3
Interim / Quarterly Report Classification · 100% confidence The document is a Form 424B3 prospectus supplement that incorporates by reference a Quarterly Report on Form 10-Q filed with the SEC for the quarterly period ended September 30, 2021. The text includes detailed unaudited financial statements, management's discussion and analysis, and other typical contents of a quarterly report. The presence of actual financial data and analysis confirms this is the report itself, not just an announcement or certification. Therefore, the document is classified as an Interim / Quarterly Report (IR).
2021-11-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.